Genmab | GEN - Current Assets

Stock Price
1,832.50
Daily Change
-21.00 -1.13%
Monthly
-13.15%
Yearly
14.67%
Q1 Forecast
1,757.86

Genmab reported DKK3.91B in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Almirall EUR 714.05M 27.09M Jun/2025
Amarin USD 628.33M 21.52M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.88B 873M Sep/2025
BioMarin Pharmaceutical USD 3.85B 49.21M Sep/2025
Demant DKK 10.08B 128M Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Fresenius Medical Care EUR 7.82B 311.36M Sep/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GN Store Nord DKK 8.64B 105M Dec/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Insmed USD 1.79B 137.6M Dec/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.88B 680M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024